>
Fa   |   Ar   |   En
   Proteotoxic Stress Induces Phosphorylation of p62/SQSTM1 by ULK1 to Regulate Selective Autophagic Clearance of Protein Aggregates  
   
نویسنده lim j. ,lachenmayer m.l. ,wu s. ,liu w. ,kundu m. ,wang r. ,komatsu m. ,oh y.j. ,zhao y. ,yue z.
منبع plos genetics - 2015 - دوره : 11 - شماره : 2 - صفحه:1 -28
چکیده    Disruption of proteostasis,or protein homeostasis,is often associated with aberrant accumulation of misfolded proteins or protein aggregates. autophagy offers protection to cells by removing toxic protein aggregates and injured organelles in response to proteotoxic stress. however,the exact mechanism whereby autophagy recognizes and degrades misfolded or aggregated proteins has yet to be elucidated. mounting evidence demonstrates the selectivity of autophagy,which is mediated through autophagy receptor proteins (e.g. p62/sqstm1) linking autophagy cargos and autophagosomes. here we report that proteotoxic stress imposed by the proteasome inhibition or expression of polyglutamine expanded huntingtin (polyq-htt) induces p62 phosphorylation at its ubiquitin-association (uba) domain that regulates its binding to ubiquitinated proteins. we find that autophagy-related kinase ulk1 phosphorylates p62 at a novel phosphorylation site s409 in uba domain. interestingly,phosphorylation of p62 by ulk1 does not occur upon nutrient starvation,in spite of its role in canonical autophagy signaling. ulk1 also phosphorylates s405,while s409 phosphorylation critically regulates s405 phosphorylation. we find that s409 phosphorylation destabilizes the uba dimer interface,and increases binding affinity of p62 to ubiquitin. furthermore,lack of s409 phosphorylation causes accumulation of p62,aberrant localization of autophagy proteins and inhibition of the clearance of ubiquitinated proteins or polyq-htt. therefore,our data provide mechanistic insights into the regulation of selective autophagy by ulk1 and p62 upon proteotoxic stress. our study suggests a potential novel drug target in developing autophagy-based therapeutics for the treatment of proteinopathies including huntington’s disease. © 2015 lim et al.
آدرس department of neurology and neuroscience,friedman brain institute,icahn school of medicine at mount sinai,new york,ny, United States, department of neurology and neuroscience,friedman brain institute,icahn school of medicine at mount sinai,new york,ny,united states,department of neurology,inselspital,university hospital bern,bern, Switzerland, department of applied biology and chemical technology,state key laboratory of chirosciences,the hong kong polytechnic university,hung hom,kowloon, Hong Kong, department of applied biology and chemical technology,state key laboratory of chirosciences,the hong kong polytechnic university,hung hom,kowloon, Hong Kong, department of pathology,st. jude children’s research hospital,memphis,tn, United States, department of genetics and genomic sciences,icahn institute for genomics and multiscale biology,icahn school of medicine at mount sinai,new york,ny, United States, department of biochemistry,niigata university,niigata-shi, Japan, department of system biology,yonsei university college of life science and biotechnology,seoul, South Korea, department of applied biology and chemical technology,state key laboratory of chirosciences,the hong kong polytechnic university,hung hom,kowloon, Hong Kong, department of neurology and neuroscience,friedman brain institute,icahn school of medicine at mount sinai,new york,ny, United States
 
     
   
Authors
  
 
 

Copyright 2023
Islamic World Science Citation Center
All Rights Reserved